Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Q3 2025 value amounting to $1.1 billion.

  • Madrigal Pharmaceuticals' Cash & Current Investments rose 1112.75% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1112.75%. This contributed to the annual value of $926.3 million for FY2024, which is 4606.62% up from last year.
  • Per Madrigal Pharmaceuticals' latest filing, its Cash & Current Investments stood at $1.1 billion for Q3 2025, which was up 1112.75% from $797.0 million recorded in Q2 2025.
  • Madrigal Pharmaceuticals' Cash & Current Investments' 5-year high stood at $1.1 billion during Q3 2025, with a 5-year trough of $153.2 million in Q3 2022.
  • In the last 5 years, Madrigal Pharmaceuticals' Cash & Current Investments had a median value of $329.5 million in 2023 and averaged $549.0 million.
  • Per our database at Business Quant, Madrigal Pharmaceuticals' Cash & Current Investments tumbled by 4878.99% in 2022 and then soared by 32979.24% in 2024.
  • Over the past 5 years, Madrigal Pharmaceuticals' Cash & Current Investments (Quarter) stood at $270.3 million in 2021, then soared by 32.71% to $358.8 million in 2022, then skyrocketed by 76.75% to $634.1 million in 2023, then surged by 46.07% to $926.3 million in 2024, then grew by 19.81% to $1.1 billion in 2025.
  • Its Cash & Current Investments was $1.1 billion in Q3 2025, compared to $797.0 million in Q2 2025 and $843.1 million in Q1 2025.